Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1994-12-16
1997-11-18
Feisee, Lila
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
4241301, 436 63, 5303881, G01N 3353, G01N 3348, A61K 39395, C07K 1600
Patent
active
056886519
ABSTRACT:
A method of selecting anti-aggregation molecules with chaperone-like activity that have characteristics including binding to a native target molecule epitope with a high binding constant and are non-inhibitory to the biological activity of the target molecule. The method molecules denaturating a target molecule in the presence of presumptative antiaggregation molecules to prevent the target molecules from self-or induced-aggregation. The nonaggregated target molecule coupled to the anti-aggregation molecule is then tested for bioactivity.
REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
Carlson et al, "Antibody assisted protein refolding" Bio/Technology, vol. , pp. 86-91, Jan. 1992.
Tomiyama et al, "Rifampicin prevents the aggregation of neurotoxicity of amyloid B protein in vitro", Biochem. and Biophys. Res. Comm., vol. 204, No. 1, pp. 76-83, Oct. 14, 1994.
Craig, E.A. "Caperones: Helpers along the pathways to protein folding" Science, vol. 260, pp. 1902-1903, Jun. 25, 1993.
Agard, D.A. "To fold or not to fold . . . " Science, vol. 260, pp. 1903-1904, Jun. 25, 1993.
Banks and Kastin, "Peptide binding in blood and passage across the blood-brain barrier" in Blood Binding and Drug Transfer, editors Tillement and Eckert, pp. 223-241, (1992).
Blond and Goldberg, "Partly native epitopes are already present on early intermediates in the folding of tryptophan synthase" PNAS (USA), 84:1147-1151 (1987).
Brems, "Solubility of different folding conformers of bovine growth hormone" Biochemistry 27:4541-4545 (1988).
Burdick et al., "Assembly and aggregation properties of synthetic Alzheimer's A4/.beta. amyloid peptide analogs" J. Biol Chem. 267, 546-554 (1992).
Bush et al., "Rapid induction of alzheimer A.beta. amyloid formation by zinc" Science 265:1465-1467 (1994).
Carlson and Yarmush, "Antibody assisted protein refolding" Bio/Technology, 10:86-91 (1992).
Chothia and Janin, "Principles of protein-protein recognition" Nature 256:705-708 (1975).
De Young et al., "Aggregation of globular proteins" Accounts of Chemical Research, 26:614-620 (1993).
Duenas et al., "Intra-and extracellular expression of an scFv antibody . . . " BioTechniques, 16:476-483 (1994).
Ellis and Van Der Viies, "Molecular chaperones" Annu. Rev. Biochem. 60:321-347 (1991).
Fraser et al., "Effects of sulfate ions on alzheimer .beta./A4 peptide assemblies . . . " J. Neurochem. 59:1531-1540 (1992).
Frederickson, Int. Rev. Neuorobiol. 31:145-238, (1989).
Gething and Sambrook, "Protein folding in the cell" Nature 355:33-45 (1992).
Goldberg, "Investigating protein conformation, dynamics and folding with monoclonal antibodies" TIBS 16:358-362 (1991).
Goloubinoff et al., "Reconstitution of active dimeric ribulose bisphosphate carboxylase . . . " Nature, 342:884-889 (1989).
Haass and Selkoe, "Cellular Processing of .beta.-amyloid precursor protein and the genesis of amyloid .beta.-peptide" Cell, 75:1039-1042 (1993).
Haber, "Engineered antibodies as pharmacological tools" Immunological Reviews, 130:189-212 (1992).
Harlow and Lane, in Antibodies, a Laboratory Manual, Chapter 6, Production of Monoclonal Antibodies, Cold Spring Harbor Laboratory, (1988).
Hattori et al., "Unfolding/refolding studies on bovine .beta.-Lactoglobulin with monoclonal antibodies as probes" J. Biol. Chem. 268:22414-22419 (1993).
Hendrick and Hartl, "Molecular chaperone functions of heat-shock proteins" Annu. Rev. Biochem, 62:349-394 (1993).
Jaenicke, "Protein folding: local structures, domains, subunits, and assebmlies" Biotechemistry, 30:3147-3161 (1991).
Mantyh et al., "Aluminum, iron, and zinc ions promote aggregation of physiological concentrations . . . " J. Neurochem. 61:1171-1173 (1993).
Marasco et al., "Design, intracellular expression and activity of a human anti-human immunodeficiency . . . " Proc. Natl. Acad. Sci. USA, 90:7889-7893 (Aug., 1993).
McLachlan et al., "Intramuscular desferrioxamine in patients with Alzheimer's disease" Lancet, 337:1304-1308 (1991).
Milstein, "Monoclonal antibodies" Scientific American, pp. 56-64 (Oct., 1980).
Pluckthun, "Mono-and bivalent antibody fragments produced in Escherichia coli: engineering, folding and antigen binding" Immunol. Reviews, 130:151-188 (1992).
Rao et al., "Chaperone-like activity of .alpha.-crystallin" J. Biol. Chem. 269:13266-13272 (1994).
Silen and Agard, "The .alpha.-lytic protease pro-region does not require a physical linkage to activate . . . " Nature, 341:462-464 (1989).
Solomon et al., "Interaction of carboxypeptidase with a monoclonal antibodies" Molec. Immunol., 21:1-12 (1984).
Solomon et al., "Localization of a highly immunogenic region of Carboxypeptidase A . . . " Biochemistry, 28:1235-1241 (1989).
Solomon and Balas, "Thermostabilization of Carboxypeptidase A by interaction with its monoclonal antibodies" Biotechnol. Appl. Biochem., 14:202-211 (1991).
Solomon and Schwartz, "Chaperone-like effect of monoclonal antibodies on refolding of heat denatured Carboxypeptidase A" J.Molec.Recog. (in press), (1995).
Stern et al., "Antibodies to the .beta.-amyloid peptide cross-react with conformational epitopes in human fibrinogen . . . " FEBS Lett. 264:43-47, (1990).
Talafous et al., "Solution structure of residues 1-28 of the amyloid .beta.-peptide" Biochemistry, 33:7788-7796 (1994).
Travis, "Putting antibodies to work inside cells" Science, 261:1114 (1993).
Tuomanen et al., "Reversible opening of the blood-brain barrier by anti-bacterial antibodies" Proc. Natl. Acad. Sci. USA, 90:7824-7828 (Aug., 1993).
Vallee and Riordan, Ann. Rev. Biochem. 38:733-794 (1969).
Vallee and Galdes, Advances in Enzymology and Related Areas of Molecular Biology, 56:282-430, (1984).
Vandenbroeck et al., "Refolding and single-step purification of porcine interferon-.gamma. . . . " Eur. J. Biochem., 215;481-486 (1993).
Welch, "How cells respond to stress" Scientific American, pp. 56-64 (May, 1993).
Wetzel, "Mutations and off-pathway aggregation of proteins" TIBTECH, 12:193-198 (1994).
Wetzel et al., Bio/Technol., 9:731-737 (1991).
Winther et al., "Refolding of a carboxypeptidase Y folding intermediate in vitro by low-affinity binding of the proregion" J. Biol. Chem., 269:22007-22013 (1994).
Wisniewski et al., "Apolipoprotein E: binding to soluble alzheimer's .beta.-amyloid" Biochem. Biphys. Res. Commun., 192:359-365 (1993).
Yankner et al., "Neurotrophic and neurotoxic effects of amyloid .beta. protein: reversal by tachykinin neuropeptides" Science 250:279-282 (1990).
Young et al., "Amylin and syndrome-X" Drug Development Research, 32:90-99 (1994).
Zhu et al., Nature 339:483-484 (1989).
Ellis et al, "The molecular chaperone concept" Biochem. Soc. Symp. 55:145-153.
Fraser et al., "Biochemistry of alzheimer's disease amyloid plaques" Clin Biochem., 26:339-349 (1993).
Friguet et al., "A convenient enzyme-linked immunosorbent assay for testing whether monoclonal antibodies . . . " J. of Immuno. Methods, 60:351-358 (1983).
Mendoza et al., "Chaperonin cpn60 from Escherichia coli protects the mitochondrial enzyme rhodanese . . . " J. Bio. Chem., vol. 265, No. 25:17631-17634 (1992).
Shinde et al., "Folding pathway mediated by an intramolecular chaperone" Proc. Natl. Acad. Sci. USA, 90:6924-6928 (Aug., 1993).
Wisniewski and Frangione, "Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid" Neuroscience Letters, 135:235-238 (1992).
Vallee, "Active center of carboxypeptidase A" Federation Proceedings, vol. 23, Part I, Jan.-Feb. (1964).
Eyler Yvonne
Feisee Lila
RAMOT University Authority For Applied Research and Development
LandOfFree
Prevention of protein aggregation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of protein aggregation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of protein aggregation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1564677